What increases the chance of a sustained remission?

State-of-the-art technologies now make it possible to decipher the aetiopathogenesis of skin diseases at a molecular level, which can be used to optimize treatment strategies. In plaque psoriasis – a disease dominated by the IL-23/Th17 signaling pathway – the response
to modern system therapeutics has already reached a very high level. Prof. Dr. med. Curdin Conrad reported that the question of how a lasting remission can be achieved after discontinuation of treatment is becoming increasingly important.